publication date: Jun. 21, 2019

Conversation with The Cancer Letter

Flatiron’s Adamson: Medicaid disparities study shows real world data is valuable for assessing policy

Blythe Adamson 2

Blythe Adamson

Senior quantitative scientist,

Flatiron Health

 

Before 2019, Blythe Adamson, a senior quantitative scientist at Flatiron Health, had never attended an annual meeting of the American Society of Clinical Oncology.

In the shower, sometime in November 2018, Adamson came up with an idea for future research: “I think we should test this hypothesis: Did ACA Medicaid expansion have an impact on racial disparities?”

At a Flatiron hackathon last December, she pitched the idea.

“This is Hackathon 18, and it kicks off on a Wednesday night in December, where they order dumplings for the whole company. So, I got up on stage and pitched this idea to recruit a team—because I knew I couldn’t do it alone.”

Three days later, Adamson and her team produced compelling preliminary results, which would be further developed to demonstrate that black patients with advanced cancer received timely treatment in states with Medicaid expansion, compared to white patients.

The study, conducted in collaboration with researchers from Yale University, showed a 4% reduction in racial disparities in time to cancer treatment—nearly eliminating the overall gap between black and white Medicaid patients in 27 states.

On June 2, at the ASCO annual meeting, Adamson’s project was the opening … Continue reading Flatiron’s Adamson: Medicaid disparities study shows real world data is valuable for assessing policy

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.